Repeating bone mineral density scans up to 8 years after initial measurements does not provide any significant benefit for predicting incident fractures in postmenopausal women with osteoporosis ...

Differences in bone density and FRAX fracture risk scores among Black and Asian women yield greater discordance in fracture risk estimation compared with White women.

Cortical, trabecular bone measures at the distal radius and tibia, as measured by high-resolution peripheral quantitative CT, can help predict fracture risk when BMD alone shows no osteoporosis.

Study finds premenopausal bone mineral density (BMD), postmenopausal BMD, and rate of lumbar spine BMD decline to be risk factors for fracture.

Bone mineral density at the femoral neck and total hip is a potential surrogate for fracture risk in clinical trials of osteoporosis drugs, according to findings presented at the American Society ...

New position statement provides a template for physicians to prevent fractures in postmenopausal women receiving aromatase inhibitor (AI) therapy for breast cancer.

AUSTIN, Texas – One year of romosozumab (Evenity) followed by 1 year of denosumab (Prolia, Xgeva) was associated with improved bone mineral density (BMD) and lower fracture incidence compared ...

Validation of surrogate endpoints for fracture could potentially lead to shorter and less expensive clinical trials, possibly spurring innovations of new drugs and procedures which might otherwise ...

Relationships were evaluated among BMD measurements at four sites—the spine, femoral neck, trochanter, and total hip—and the risk of fractures at the spine, hip, forearm, or proximal humerus ...

Poor vitamin K status is associated with inflammation and low areal bone mineral density (BMD) among patients with end-stage renal disease.